arrow
Back
S

Sarah Cannon Research Institute

Scholars1.5K
Papers1.2K
Citations343
Related Papers (1174)
Publication Date
Incidence of Human Leukocyte Antigen (HLA) Class I Antibodies and Impact on Platelet Engraftment, Transfusions and Bleeding in Recipients of Gene Therapy for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia
err2026-08-15
err0
PREAI
errHaydar Frangoul; Meghann McManus; Clinton Carroll; Sallyanne Fossey; Mathew Rowe; Addison Roelandts; Eileen McCartney; Shelby Aide; Amanda Stults; Sam Forbes; Christy Riggins; Kala Morgan; Rayea Tilman; Morgan Duckworth; Natalie Davis; Katie Bruce; Minoo Battiwala; Jennifer Domm; Misty Evans
errShare
errSave
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
err2026-08-11
err0
errOAAI
errIda Aronchik; Sumit Kar; Yongxian Zhuang; Ethan Ahler; Lick Pui Lai; Vidya Seshadri; Yu Chi Yang; Ashenafi Bulle; Marie Menard; Biswadeep Nayak; Mark P. Labrecque; Julien Dilly; Eejung Kim; Lingyan Jiang; Jason Yano; Urszula N. Wasko; Ciara Helland; Sean Bredeson; Brett Garrick; Yevgeniy Gindin; Brad Sickler; Xing Wei; Kyle Seamon; Jingjing Jiang; Kian-Huat Lim; Matthew Holderfield; Elsa Quintana; Aparna Hegde; Zeena Salman; Alexander Starodub; Alexander Spira; Wungki Park; David S. Hong; Minal Barve; Meredith Pelster; David Sommerhalder; Salman R. Punekar; Ignacio Garrido-Laguna; Brian M. Wolpin; Anirban Maitra; W. Clay Gustafson; Steve Kelsey; Jacqueline A. M. Smith; Kevin K. Lin; Andrew J. Aguirre; Mallika Singh
errShare
errSave
CLTR-07 ELECTRA: AN OPEN-LABEL, MULTICENTER, PHASE 1B/2 STUDY OF ELACESTRANT IN COMBINATION WITH ABEMACICLIB IN PATIENTS WITH BRAIN METASTASES FROM ER+/HER2– BREAST CANCER
err2026-08-07
err0
errOAAI
errNancy U Lin; Milana Bergamino Sirven; Kyung-hun Lee; Timucin Cil; Haythem Ali; Manuel Ruiz Borrego; Jugón Shin; Sercan Aksoy; Mahmut Gumus; Cengiz Karacin; Cristian Villanueva; Eva Ciruelos Gil; José A García-Sáenz; Giuseppe Curigliano; Michaela Palleschi; Annalisa Fontana; Alessandra Fabi; Angela Swampillai; Jee Hung Kim; Sung-Bae Kim; Umut Dimirci; Erika Hamilton; Alessandro Di Sanzo; Faten Koraichi Auriol; Bartomeu Piza Vallespir; Tomer Wasserman; Nuhad Ibrahim
errShare
errSave
PP01.11: Real-World Outcomes of RET Inhibitor Switching in RET Fusion–Positive NSCLC Patients
err2026-07-03
err0
PREAI
errKatherine E. Smith; Parth A. Desai; Alexander Drilon; Christine Garcia; Aaron S. Mansfield; Aaron Sheppard; Amber Thomassen; Vivek Subbiah
errShare
errSave
errShare
errSave
Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings
err2026-06-26
err0
errOAAI
errTara Graff; Edward Pearson; Sairah Ahmed; Krish Patel; Matthew Lunning
errShare
errSave
Corrigendum to ‘Patient-Reported Outcomes With Consolidation Durvalumab Versus Placebo After Concurrent Chemoradiotherapy in Limited-Stage SCLC: Results From the Phase 3 ADRIATIC Trial’ [Journal of Thoracic Oncology volume 21 issue 6 (2026) 103564]
err2026-06-23
err0
errOAAI
errSilvia Novello; David R. Spigel; Jian Fang; Yuanbin Chen; Yoshitaka Zenke; Ki Hyeong Lee; Alejandro Navarro; Eva Lotte Buchmeier; John Wen-Cheng Chang; Yoshimasa Shiraishi; Mustafa Özgüroğlu; Yu Jung Kim; Nguyen Thi Thai Hoa; Sayed M.S. Hashemi; Anne C. Chiang; Ralph Turner; Helen Mann; Yuka Olivo; Haiyi Jiang; Suresh Senan
errShare
errSave
Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure
err2026-06-03
err0
errOAAI
errLY Lansaol Yang; ME Michael E. Bryan; EV Eduardo Veiga; IL Ian Lowenhoff; AW Alex Wan; IM Isam Mina; TA Tracey Allen; JA Javier Antonio Alfaro; GB Gareth Bloomfield; JB Julian Beach; KD Kristen Dahlgren; NK Nick K. Davis; EF Elisa Fontana; SG Spyridon Gennatas; QG Qamar Ghafoor; FH Franck Housseau; DL Daniel Lubelski; ZZ Zhehao Zhang; MH Matt Hancock; WI William Ince; DJ Dominic James; SK Sam Khan; VK Victoria Kunene; JM John McGrane; GC Gerard Cathal Millen; BM Benjamin Moxley-Wyles; DN David Narganes-Carlon; MP Miranda Payne; PJ Paul J. Ross; RR Rene Roux; MR Michael Rowe; RL Rebecca Lee; JS Jerry S. H. Lee; JK Justin K. H. Liu; DA Deepak Aggarwal; AB Aaron B. S. Teoh; CT Chrissie Thirlwell; MT Michael Tilby; SS Stefan Symeonides; IW Isabella Watts; DB David B. Agus; SJ Santa J. Ono; TE Tim Elliott; PC Paul Calleja; LY Lennard Y. W. Lee
errShare
errSave
Safety analyses of the INAVO120 randomised phase III trial of inavolisib or placebo with palbociclib–fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative, endocrine-resistant advanced breast cancer
err2026-05-27
err0
errOAAI
errS.-A. Im; K. Kalinsky; K.L. Jhaveri; S. Loibl; N. Turner; C. Saura; P. Schmid; S. Loi; E. Hamilton; N. Karadurmus; S. Wang; A.A. Awan; E.M. Ciruelos; C.-F. Chung; E. Thanopoulou; N. Shankar; S. Lim; Y. Jin; C. Song; D. Juric
errShare
errSave
Circulating cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) in oncology: from technological advances to clinical applications
err2026-05-25
err0
errOAAI
errEdoardo Francini; Sara Bleve; Giuseppe Nicolo Fanelli; Mara Serena Serafini; Filippo Pederzoli; Alessandra Ferri; Erika Minonne; Jacopo Venturini; Silvia Rodrigues; Hubert Pakula; Cristian Lolli; Massimo Cristofanilli; Pier Vitale Nuzzo
errShare
errSave
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma
err2026-05-16
err0
PREAI
errMatthew D. Galsky; Alexandra Drakaki; Arnab Basu; Bradley McGregor; Jens Bedke; Yohann Loriot; Eiji Kikuchi; Jun Guo; Benjamin Garmezy; Srikala S. Sridhar; Parminder Singh; Vadim S. Koshkin; Mark Fleming; Gunnar Klauss; Daisy Lin; Chelsea Liu; Andrea B. Apolo; Thomas Powles
errShare
errSave
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy
err2026-05-11
err0
errOAAI
errMilan Radovich; James Wacker; Jeffrey Solzak; Hongseok Tae; Jennifer R. Ribeiro; Todd Maney; Bradley Hancock; James Hamrick; George W. Sledge; Manmeet S. Ahluwalia; Stephen V. Liu; Emil Lou; Vivek Subbiah; Balazs Halmos; Daniel Magee; David B. Spetzler
errShare
errSave
First-in-human study of the dual A2A/A2B adenosine receptor antagonist muvadenant (M1069) in patients with advanced solid tumors
err2026-05-07
err0
errOAAI
errL.L. Siu; M.E. Gutierrez; L. Pudelko; K. Ruth; M.A.F.N. Filho; R. Zaynagetdinov; P. Hu; T. Kitzing; B.K. Guenhan; I. Durutovic; M. McKean
errShare
errSave
Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma
err2026-05-04
err0
PREAI
errYuxin Liu; Clifton Mo; Shonali Midha; Monique Hartley-Brown; Hans C. Lee; Joseph Franz; Omar Nadeem; Taylor Nicholson; Taya Jamal Salman; Anne Fortune; Robert Rifkin; Lauren E. Merz; Jesus Berdeja; Jacob Laubach; Peter O’Gorman; Paul G. Richardson
errShare
errSave
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial
err2026-04-27
err0
errOAAI
errJoyce O’Shaughnessy; Francois-Clement Bidard; Patrick Neven; Monica Lis Casalnuovo; Philippe Aftimos; Cristina Saura; Nadia Harbeck; Lisa A. Carey; Giuseppe Curigliano; Jose A. Garcia-Saenz; Maria Fernandez Abad; Larissa de Paula; Yeon Hee Park; Ozgur Ozyilkan; Maria Munoz; Emily Barrett; Shanshan Cao; Aarti Chawla; Komal L. Jhaveri
errShare
errSave
Biomarker analysis of cadherin 6 and folate receptor alpha (FRα) expression, and raludotatug deruxtecan (R-DXd) antitumor activity by FRα status, in patients with platinum-resistant ovarian cancer from REJOICE-Ovarian01 and a first-in-human Phase 1 study of R-DXd
err2026-04-23
err0
PREAI
errKathleen Moore; Isabelle Ray-Coquard; Erika Hamilton; Kosei Hasegawa; Debra Richardson; Alexander Philipovskiy; Kazuki Sudo; Jung-Yun Lee; Nicoletta Colombo; David Garcia-Illescas; Sany Hoxha; Madan Kundu; Yusuke Myobatake; Connor Mailley; Sandra Re; Tsuyoshi Hirata; Cynthia Turcotte; Weiguo Feng; Nanae Izumi
errShare
errSave
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease
err2026-04-02
err5
PREAI
errHanna, Rabi; Frangoul, Haydar; Pineiro, Luis; McKinney, Christopher; Mapara, Markus; Dalal, Jignesh; Rangarajan, Hemalatha G.; Atkins, Harold; Sharma, Akshay; Chang, Kai-Hsin; Jaskolka, Michael C.; Kim, Keunpyo; Yu, Qifeng; Mei, Baisong; Afonja, Olubunmi; Walters, Mark C.
errShare
errSave
CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
err2026-04-02
err4
PREAI
errFrangoul, Haydar; Hanna, Rabi; Walters, Mark C.; Kao, Roy L.; Carroll, Clinton; Mcmanus, Meghann; Chang, Kai-Hsin; Jaskolka, Michael C.; Kim, Keunpyo; Yu, Qifeng; Badamosi, Nnenna; Mei, Baisong; Afonja, Olubunmi; Thompson, Alexis
errShare
errSave
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma
err2026-04-01
err0
errOAAI
errDummer, Reinhard; Sandhu, Shahneen; Miller Jr, Wilson H.; Butler, Marcus O.; Taylor, Matthew H.; Heinzerling, Lucie; Blank, Christian U.; Couselo, Eva Munoz; Burris, Howard A.; Postow, Michael A.; Chmielowski, Bartosz; Middleton, Mark R.; Berking, Carola; Hassel, Jessica C.; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F.; Polli, Anna; Harney, Allison S.; Di Pietro, Alessandra; Ascierto, Paolo A.
errShare
errSave